Status:
COMPLETED
The Effects of Bovine Colostrum in Bone Metabolism in Humans
Lead Sponsor:
Petros Dinas
Collaborating Sponsors:
European Commission
Conditions:
Osteopenia
Osteoporosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Osteoporosis constitutes a major public health concern. For instance, in European Union 1 in 3 women and at least 1 in 6 men will suffer an osteoporotic fracture during their lifespan. The burden of o...
Detailed Description
Postmenopausal women (without any bone condition), osteopenia and osteoporosis patients (female and male) will be invited to join the study. Participants enrolling the project will be first measured o...
Eligibility Criteria
Inclusion
- Postmenopausal women (no menses for the last year at least);
- Osteoporosis patients (female): T-score\<-2.5 at the femoral neck (or other anatomical site);
- Osteoporosis patients (male): T-score\<-2.5 at the femoral neck (or other anatomical site)
- Osteopenia patients (female): T-score\<-1.0 at the femoral neck (or other anatomical site);
- Osteopenia patients (male): T-score\<-1.0 at the femoral neck (or other anatomical site)
- Patients taking drugs/ supplements for osteoporosis will be accepted in the study after going through a wash-up period
Exclusion
- Women with irregular menses (i.e. with no established menopause)
- Patients taking medications for other diseases known to interfere with bone metabolism
- Patients with other chronic diseases (e.g. diabetes)
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04040010
Start Date
September 1 2019
End Date
February 29 2020
Last Update
November 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FAME Lab, Department of Exercise Science, University of Thessaly
Trikala, Thessaly, Greece, 42100